SCHEMBL19782783

SCHEMBL19782783

COc1cccc2nc(SC)sc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 5/20 0.43
ALDH1A1 P00352 5/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
KDM4E B2RXH2 3/20 0.43
HPGD P15428 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HCRTR1 O43613 2/20 0.43
MAPT P10636 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
CYP3A4 P08684 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
PPARG P37231 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30189894 1.00 NQO2 (0.43) NQO2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL6691814 0.88 ALDH1A1 (0.47) NQO2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL6901949 0.88 HSP90AA1 (0.48) NQO2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL6690657 0.79 HSP90AA1 (0.43) NQO2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL6697802 0.79 HSP90AA1 (0.39) NQO2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL2749954 0.77 NPC1 (0.45) ALDH1A1NPC1RAB9AKDM4EHPGD
SCHEMBL660168 0.77 ALDH1A1 (0.43) ALDH1A1NPC1RAB9AKDM4EHPGD
SCHEMBL8040045 0.77 NQO2 (0.47) NQO2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL2749006 0.75 ALDH1A1 (0.58) NQO2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL2748734 0.75 NQO2 (0.46) NQO2ALDH1A1NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109689647-B Bicyclic heteroaryl substituted compounds 百时美施贵宝公司 2023-01-20 CN disclosed
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-06-03 US disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
WO-2018013774-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, PF4 NQO2 756/4885ALDH1A1 1618/4885NPC1 2639/4885
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, F12 NQO2 851/4885ALDH1A1 1598/4885NPC1 2194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.